Showing results (21-30 of 59) with videos related to
Sort By:
Pageof 6
Neuro-Oncology Advances|August 4, 2021
The effects of palbociclib in combination with radiation in preclinical models of aggressive meningiomaCraig Horbinski, Guifa Xi, Yufen Wang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2007
Two consecutive phase II window trials of irinotecan alone or in combination with vincristine for the treatment of metastatic rhabdomyosarcoma: the Children's Oncology GroupAlberto S Pappo, Elizabeth Lyden, Phillip Breitfeld, et al.Pediatric Blood & Cancer|September 10, 2014
Efficacy of CPX-351, (cytarabine:daunorubicin) liposome injection, against acute lymphoblastic leukemia (ALL) xenograft models of the Pediatric Preclinical Testing ProgramHernan Carol, Mannie M Y Fan, Troy O Harasym, et al.Plos One|August 30, 2014
Insulin-like growth factor 1 receptor and response to anti-IGF1R antibody therapy in osteosarcomaYu Cao, Michael Roth, Sajida Piperdi, et al.Bioorganic & Medicinal Chemistry|July 26, 2014
Cytotoxicity of synthesized 1,4-naphthoquinone analogues on selected human cancer cell linesNavneet Kishore, Brigitte Binneman, Anita Mahapatra, et al.Pediatric Blood & Cancer|August 26, 2015
Targeting Glycoprotein NMB With Antibody-Drug Conjugate, Glembatumumab Vedotin, for the Treatment of OsteosarcomaMichael Roth, David M Barris, Sajida Piperdi, et al.NPJ Precision Oncology|April 17, 2025
Benchmarking mouse contamination removing protocols in patient-derived xenografts genomic profilingMukund Bhandari, Funan He, Anna Rogojina, et al.Bioorganic & Medicinal Chemistry|September 25, 2007
Activity of 7-methyljuglone derivatives against Mycobacterium tuberculosis and as subversive substrates for mycothiol disulfide reductaseAnita Mahapatra, Sannah P N Mativandlela, B Binneman, et al.Nature Communications|November 2, 2018
MiR-584-5p potentiates vincristine and radiation response by inducing spindle defects and DNA damage in medulloblastomaNourhan Abdelfattah, Subapriya Rajamanickam, Subbarayalu Panneerdoss, et al.Oncotarget|February 1, 2014
Pharmacokinetic modeling optimizes inhibition of the 'undruggable' EWS-FLI1 transcription factor in Ewing SarcomaSung-Hyeok Hong, Sarah E Youbi, S Peter Hong, et al.Pageof 6